CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $609,000 | +134.2% | 78,821 | +124.0% | 0.00% | – |
| Q3 2019 | $260,000 | -50.3% | 35,182 | -24.5% | 0.00% | -100.0% |
| Q2 2019 | $523,000 | +4.4% | 46,582 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $501,000 | -45.1% | 46,582 | -23.0% | 0.00% | -50.0% |
| Q4 2018 | $913,000 | -23.9% | 60,482 | -6.8% | 0.00% | 0.0% |
| Q3 2018 | $1,200,000 | +11.2% | 64,882 | +37.5% | 0.00% | 0.0% |
| Q2 2018 | $1,079,000 | -12.8% | 47,200 | +8.5% | 0.00% | 0.0% |
| Q1 2018 | $1,238,000 | – | 43,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |